Redmile Group, LLC
SEC insider (Form 3/4/5 filer). CIK 0001425738. 10% Owner at Attovia Therapeutics, Inc. (ATTO) and 6 other issuers. 49 reported Form 4/5 transactions since Sep 2024; latest on Aug 6, 2026. Located in LARKSPUR, CA.
Companies Redmile Group, LLC has filed insider reports for
- Attovia Therapeutics, Inc. (ATTO): 10% Owner
- Atara Biotherapeutics, Inc. (ATRA): Director
- FATE THERAPEUTICS INC (FATE): Director, 10% Owner
- ADC Therapeutics SA (ADCT): 10% Owner
- Shattuck Labs, Inc. (STTK): Director, 10% Owner
- IGM Biosciences, Inc. (IGMS): Director, 10% Owner
- Augmedix, Inc. (AUGX): Director, 10% Owner
Redmile Group, LLC
CIK: 0001425738
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (49 total)
- Aug 6, 2026ATTO
Attovia Therapeutics, Inc.
PurchaseIndirect400K shares at avg. $17.00$6.8M - Aug 6, 2026ATTO
Attovia Therapeutics, Inc.
ConversionIndirect782.9K shares- - Aug 6, 2026ATTO
Attovia Therapeutics, Inc.
PurchaseDirect200K shares at avg. $17.00$3.4M - Jul 22, 2026ATRA
Atara Biotherapeutics, Inc.
Tax PaymentIndirect60 shares- - Jul 22, 2026ATRA
Atara Biotherapeutics, Inc.
ExerciseIndirect195.2K shares- - Jun 12, 2026FATE
FATE THERAPEUTICS INC
AwardIndirectStock Option (Right to Buy)
87.9K shares- - Apr 20, 2026FATE
FATE THERAPEUTICS INC
OtherIndirectCash-settled Swaps
266.3K shares- - Apr 20, 2026FATE
FATE THERAPEUTICS INC
OtherDirectCash-settled Swaps
266.3K shares- - Apr 20, 2026FATE
FATE THERAPEUTICS INC
OtherIndirect9M shares- - Apr 20, 2026FATE
FATE THERAPEUTICS INC
OtherDirect9M shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Aug 6, 2026 |  ATTO Attovia Therapeutics, Inc. | Purchase | 400,000 | $17.00 | $6,800,000 | Indirect |
| Aug 6, 2026 | ATTO Attovia Therapeutics, Inc. | Conversion | 782,854 | - | $0 | Indirect |
| Aug 6, 2026 | ATTO Attovia Therapeutics, Inc. | Purchase | 200,000 | $17.00 | $3,400,000 | Direct |
| Jul 22, 2026 |  ATRA Atara Biotherapeutics, Inc. | Tax Payment | 60 | - | $0 | Indirect |
| Jul 22, 2026 | ATRA Atara Biotherapeutics, Inc. | Exercise | 195,211 | - | $0 | Indirect |
| Jun 12, 2026 |  FATE FATE THERAPEUTICS INC | Award Stock Option (Right to Buy) | 87,900 | - | - | Indirect |
| Apr 20, 2026 | FATE FATE THERAPEUTICS INC | Other Cash-settled Swaps | 266,280 | - | - | Indirect |
| Apr 20, 2026 | FATE FATE THERAPEUTICS INC | Other Cash-settled Swaps | 266,280 | - | - | Direct |
| Apr 20, 2026 | FATE FATE THERAPEUTICS INC | Other | 8,977,624 | - | $0 | Indirect |
| Apr 20, 2026 | FATE FATE THERAPEUTICS INC | Other | 8,977,624 | - | $0 | Direct |
1-10 of 49 transactions